Impact BioMedical Inc. Approves Issuance of 31.9 Million Shares to DSS, Inc
I'm PortAI, I can summarize articles.
Impact BioMedical Inc. has approved the issuance of 31.9 million shares to DSS, Inc. This decision was made by the Board of Directors and majority stockholders on July 14, 2025, and will be implemented after a designated period. The company, based in Houston, Texas, aims to advance its strategic objectives in the biomedical sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments